Omeprazole: A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs

Drugs

Volumn 56, Issue 3, 1998, Pages 447-486

  Langtry, Heather D ^a   Wilde, Michelle I ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BISMUTH DERIVATIVE; CIMETIDINE; CISAPRIDE; LANSOPRAZOLE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; RANITIDINE; STOMACH SECRETION INHIBITOR;

ABDOMINAL PAIN; CHILDHOOD DISEASE; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; ESOPHAGITIS; FLATULENCE; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HEADACHE; HEALING; HELICOBACTER PYLORI; PEPTIC ULCER; RELAPSE; REVIEW; STOMACH ACID SECRETION; VERTIGO;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE;

HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0031664975     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856030-00012     Document Type: Review

References (304)

1. McTavish D, Buckley MM-T, Heel RC. Omeprazole: an updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 1991; 42: 138-70
2. Wilde MI, McTavish D. Omeprazole: an update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994 Jul; 48: 91-132
3. Markham A, McTavish D. Clarithromycin and omeprazole: as Helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders. Drugs 1996 Jan; 51: 161-78
4. Alarcón T, Domingo D, Sánchez I, et al. In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1996 Dec; 15: 937-40
5. Cederbrant G, Kahlmeter G, Schalén C, et al. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin. erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J Antimicrob Chemother 1994 Dec; 34: 1025-9
6. Andersson T, Pharmocokinetics, metabolism and interactions of acid pump inhibitors: focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 1996 Jul; 31: 9-28
7. Unge P, Andersson T. Drug interactions with proton pump inhibitors. Drug Saf 1997 Mar; 16: 171-9
8. Danz-Neeff H, Brunner G. Comparative kinetic studies with the three proton pump inhibitors omeprazole, lansoprazole and pantoprazole in patients with complete liver cirrhosis [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 90
9. Jacqz-Aigrain E, Bellaich M, Faure C, et al. Pharmacokinetics of intravenous omeprazole in children. Eur J Clin Pharmacol 1994; 47 (2): 181-5
10. Gustavson LE, Kaiser JF, Edmonds AL, et al. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995 Sep; 39: 2078-83
11. Kees F, Ittner KP, Mair G. Kinetic synergism: omeprazole and roxithromycin [abstract]. 20th International Congress of Chemotherapy; 1997 Jun 29-Jul 3: 135
12. Böttiger Y, Tybring G, Götharson E, et al. Inhibition of the sulfoxidalion of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin. Clin Pharmacol Ther 1997 Oct; 62: 384-91
13. Vreeburg EM, De Vlaam-Schluter GM, Trienekens PH, et al. Lack of effect of omeprazole on oral acenocoumarol anticoagulant therapy. Scand J Gastroenterol 1997 Oct; 32: 991-4
14. Stuht H, Lode H, Koeppe P. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics. Antimicrob Agents Chemother 1995 May; 39: 1045-9
15. Schenk BE, Festen HPM, Kuipers EJ, et al. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cohalamin. Aliment Pharmacol Ther 1996 Aug; 10: 541-5
16. Pilotto A, Franceschi M, Lagni M, et al. The effect of omeprazole on serum concentrations of theophylline, pepsinogens A and C, and gastrin in elderly duodenal ulcer patients. Am J Ther 1995 Jan; 2: 43-6
17. Kusumoto M, Ueno K, Tanaka K, et al. Lack of pharmacokinetic interaction between mexiletine and omeprazole. Ann Pharmacother 1998 Feb; 32: 182-4
18. Böttiger Y, Bertilsson L. No effect on plasma carbamazepine concentration with concomitant omeprazole treatment [letter]. Clin Drug Invest 1995 Mar; 9: 180-1
19. Nilsson M, Edsbäcker S, Larsson P, et al. Budesonide pharmacokinetics is not affected by omeprazole [abstract]. Gut 1995; 37 Suppl. 2: 51
20. Hussain F, Trudgill N, Riley S. Mesalazine release from a pH-dependant formulation: effect of concurrent omeprazole administration [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 840
21. Andersson T, Bredberg E, Naesdal J, et al. Lack of drug-drug interaction between three different non-steroidal anti-inflammatory drugs and omeprazole [abstract]. Am J Gastroenterol 1997 Sep; 92: 1609
22. Xia H-X, Talley NJ, Keane CT, et al. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci 1997 Sep; 42: 1821-34
23. Veldhuyzen-van-Zanten SJ, Sherman PM, Hunt RH. Helicobacter pylori: new developments and treatments. Can Med Assoc J 1997 Jun 1; 156: 1565-74
24. Tytgat GN. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994 Aug; 8: 359-68
25. Unge P. Review of Helicobactcr pylori eradication regimens. Scand J Gastroenterol 1996; 31 Suppl. 215: 74-81
26. Pounder RE, Williams MP. The treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997 Apr; 11 Suppl. 1: 35-41
27. 14C urea breath test [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 102
28. Chey WD, Fey D, Scheiman JM, et al. The role of acid suppression in the effects of lansoprazole and ranitidine in the 14C-urea breath test [abstract]. Gastroenterology 1996; 110 (4): A80
29. Stermer E, Tabak M, Potasman I, et al. Effect of ranitidine on the urea breath test: a controlled trial. J Clin Gastroenterol 1997; 25: 323-7
30. 2-receptor antagonists on test result. Scand J Gastroenterol 1998; 33: 364-9
31. Adamek RJ, Szymanski C, Pfaffenbach B. Pantoprazole versus omeprazole in one-week low-dose triple therapy for cure of H. pylori infection. Am J Gastroenterol 1997 Oct; 92: 1949-50
32. Adamek RJ, Opferkuch W, Pfaffenbach B, et al. Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin. Am J Gastroenterol 1996 Jan; 91: 98-100
33. Adamek RJ, Opferkueh W, Wegener M. Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect. Am J Gastroenterol 1994 Sep; 89: 1602-3
34. Adeyemi EO, Olsen JE, Robinson MP, et al. A study of the efficacy of high dose augmentin or clarithromycin plus omeprazole in the treatment of H. pylori-positive peptic ulcer and chronic active gastritis - a pilot study [abstract]. Eur J Clin Invest 1996; 26 Suppl. 1: 18
35. Al-Assi MT, Cole RA, Karttunen TJ, et al. Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. Am J Gastroenterol 1995 Sep; 90: 1411-4
36. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 1995 Feb; 9: 41-6
37. Al-Assi MT, Genta RM, Graham DY. Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1994 Apr; 8: 254-62
38. Annibale B, D'Ambra G, Luzzi I, et al. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients? Am J Gastroenterol 1997 May; 92: 790-4
39. Archimandritis A, Balatsos V, Delis V, et al. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine: a 12-month follow-up. J Clin Gastroenterol 1995 Jan; 20: 12-6
40. Atherton JC, Hudson N, Kirk GE, et al. Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals. Aliment Pharmacol Ther 1994 Oct; 8: 495-8
41. Back S, Carling L, Ekström P, et al. Eradication of Helicobacter pylori with either phenoxymethylpenicillin, benzylpenicillin or amoxicillin in combination with omeprazole: a Swedish multicentre study [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 50
42. Bank S, Blumstein M, Greenberg R, et al. Amoxicillin 1 gram tid when combined with omeprazole gives high HP eradication rates: preliminary report [abstract]. Gastroenterology 1995 Apr: 108 Suppl.: 52
43. Bayerdörffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995 May; 108: 1412-7
44. Bazzoli F. Italian omeprazole triple therapy - a 1-week regimen. Scand J Gastroenterol 1996; 31 Suppl. 215: 118
45. Bazzoli F, Zagari M, Pozzato P, et al. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, bouble-blind controlled study. Aliment Pharmacol Ther 1998; 12: 439-45
46. Bazzoli F, Zagari RM, Fossi S, et al. Effect of omeprazole, clarithromycin and tinidazole on the eradication of Helicobacter pylori and healing of gastric ulcer [abstract]. Gut 1996; 39 Suppl. 3: 142
47. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994 Sep; 6: 773-7
48. Bell GD, Bate CM, Axon ATR, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind randomized trial. Aliment Pharmacol Ther 1995 Oct; 9: 513-20
49. Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996 Feb; 91: 258-63
50. Bianchi Porro CJ, Lazzaroni M, Bargiggia S, et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol 1996 Apr; 91: 695-700
51. Bigard MA, Delchier JC, Rianchi G, et al. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin. Aliment Pharmacol Ther 1998; 12: 383-8
52. Boridy TJ, Andrews P, Fracchia G, et al. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995 Oct; 37: 477-81
53. Bouali MR, Khediri MF, Rejeb AB, et al. Three days vs seven days antibiotics in triple therapy with omeprazole for H. pylori eradication [abstract]. Gut 1997 Oct; 41 Suppl. 3: A205
54. Breuer T, Kim JG, Gurer IE, et al. Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1997 Jun; 11: 523-7
55. Burette A, Lamy V, Ligny G, et al. Dual or triple therapy combining omeprazole with amoxicillin and/or clarithromycin for H. pylori infection [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 80
56. Caroli A, Sperti C, Zanlungo P, et al. Amoxicillin plus omeprazole in the treatment of the Helicobacter pylori infection: comparison between two different amoxicillin dosages [abstract]. Ital J Gastroenterol 1995 Dec; 27 Suppl. 1: 55
57. Caroli A, Monica F, Sperti C, et al. Lansoprazole versus omeprazole in double therapy with amoxicillin for cure of Helicobacter pylori infection [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 83
58. Caselli M, Ruina M, Gallerani L, et al. Azithromycin and increasing doses of omeprazole for the eradication of Helicobacter pylori [abstract]. Gut 1996; 39 Suppl. 2: 31
59. Caselli M, Trevisani L, Tursi A, et al. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1997 Jan; 9: 45-8
60. Caselli M, Ruina M, Fabbri P, et al. A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication. J Antimicrob Chemother 1996 Apr; 37: 849-50
61. Catalano F, Privitera U, Branciforte G, et al. Omeprazole vs two different doses of lansoprazole in triple therapy on H. pylori positive duodenal ulcer [abstract]. Gut 1996; 39 Suppl. 2: 32
62. Catalano F, Catanzaro R, Bentivegna A, et al. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. Aliment Pharmacol Ther 1998; 12: 59-62
63. Cataldo MG, Brancato D, Donatelli M, et al. Treatment of patients with duodenal ulcer positive for Helicobacter pylori infection: ranitidine or omeprazole associated with colloidal bismuth subcitrate plus amoxicillin. Curr Ther Res Clin Exp 1996 Mar; 57: 168-74
64. Chiba N. Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. Am J Gastroenterol 1996 Oct; 91: 2139-43
65. Ching CK, Chan YK, Ng WC. The combination of omeprazole, amoxycillin and clarithromycin eradicates Helicobacter pylori in 95% of cases - 7-day equals 10-day therapy [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 87
66. Chow WH, Kwan WK, Cheung SF, et al. Efficacy of low dose, short course of omeprazole + metronidazole + clarithromycin in the treatment of gastric ulcer [abstract]. J Gastroenterol Hepatol 1997 Dec; 12 Suppl. 1: 194
67. Chua A, Singh GP. A comparison of two treatment regimens for Helicobacter pylori associated non-ulcer dyspepsia: preliminary results [abstract]. J Gastroenterol Hepatol 1996; 11 Suppl. 2: 60
68. Dalla Libera M, Pazzi P, Carli G, et al. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. Aliment Pharmacol Ther 1996 Apr; 10: 203-6
69. De Boer W, Driessen W, Janaz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995 Apr 1; 345: 817-20
70. de Boer WA, Driessen WMM, Jansz AR, et al. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995 Dec; 7: 1189-94
71. De Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995 Dec; 9: 633-8
72. Delchier JC, Elamine I, Goldfain D, et al. Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996 Jun; 10: 263-8
73. Deltenre M, Jonas C, van Gossum M, et al. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients. Eur J Gastroenterol Hepatol 1995 Aug; 7 Suppl. 1: 39-44
74. De Medici A, Saccà N, Rodino S, et al. Efficacy and tolerability of two different therapeutic regimens in the eradication of Helicobacter pylori [abstract]. Ital J Gastroenterol 1995 Dec; 27 Suppl. 1: 87
75. Di Mario F, Kusstatscher S, Dal Bò N, et al. Quadruple therapy versus ranitidine bismuth citrate after failure of standard triple therapy [abstract]. Gut 1997 Oct; 41 Suppl. 3: A211
76. Ding PH. Efficacy of one week low dose triple therapy in eradicating Helicobacter pylori in patients with gastric ulcer [abstract]. J Gastroenterol Hepatol 1996; 11 Suppl. 2: 60
77. Dobrucali A, Tuncer M, Eralp YT, et al. One-day high-dose combined therapy of Helicobacter pylori infection. Dig Dis Sci 1997 Oct; 42: 2169-70
78. Doll J, Fléjou JF, Mégraud F, et al. Effect of the galenic formulation of amoxicillin and the dose of omeprazole on the efficacy of the combination omeprazole-amoxicillin for eradication of Helicobacter pylori [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 97
79. Dovas A, Gabranis J. Eradication of H.pylori and healing of duodenal ulcer with omeprazole, clarithromycin and tinidazole [abstract]. 20th ICC 1997 Jun 29: 136
80. Erdag S, Bójko JB, Burlage M, et al. Optimal compliance eliminates differences in eradication rates between 2-week dual and 1-week triple therapy for Helicobacter pylori gastritis [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 103
81. Fleischmann R, Demharter R, Barnert J, et al. Eradication of Helicobacter pylori in peptic ulcer disease with amoxycillin, 2.0g, and omeprazole, 80 or 120mg: a prospective randomized trial. Eur J Gastroenterol Hepatol 1997 Jun; 9: 593-8
82. Forné M, Viver JM, Esteve M, et al. Randomized clinical trials comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing. Am J Gastroenterol 1998 Jan; 93: 35-8
83. Forné M, Viver JM, Espinós JC, et al. Impact of colloidal bismuth subcitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. Am J Gastroenterol 1995 May; 90: 718-21
84. Georgopoulos S, Karatapanis S, Mentis A, et al. Influence of metronidazole resistance on the efficacy of two, short-term, triple therapies based on clarithromycin, in the eradication of Helicohacter pylori (Hp) [abstract]. Gut 1996; 39 Suppl. 3: 140-1
85. Gisbert JP, Mur M, Boixeda D, et al. One-week therapy with omeprazole, clarithromycin and amoxycillin: high efficacy in eradicating Helicobacter pylori and healing duodenal ulcer [in Spanish]. Med Clin 1997 Apr 12; 108: 524-9
86. Goenka MK, Das K, Vaiphei K, et al. Helicobacter pylori eradication - evaluation of triple therapy containing omeprazole. Indian J Gastroenterol 1996 Jan; 15: 1-3
87. Goh KL, Parasakthi N, Chuah SY, et al. Comparison of two 1-week low-dose omeprazole triple therapies - optimal treatment for Helicobacter pylori infection? Aliment Pharmacol Ther 1997 Dec; 11: 1115-8
88. Graham KS, Malaty H, El-Zimaity HMT, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995 Sep; 90: 1415-8
89. Gutiérrez O, Melo M, Sierra F, et al. Omeprazole plus triple therapy in the eradication of Helicobacler pylori [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 106
90. Habu Y, Mizuno S, Kiyota K, et al. Triple therapy of omeprazole + amoxicillin + clarithromycin is effective for the cure of Helicobacter pylori infection in gastric and duodenal uleer patients. Results of a randomized study involving 120 patients in Japan [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 126
91. Habu Y, Mizuno S, Hirano S, ct al. Randomized comparison of 1 week and 2 weeks of omeprazole, amoxicillin, and clarithromycin treatment for the cure of Helicobacter pylori infection in gastric and duodenal ulcer patients [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 136
92. Hermida C, Moreno JA, Carpintero P, et al. Triple therapy (omeprazole + amoxicillin 4 clarithromycin) for Helicobacter pylori eradication in patients with peptic ulcer. No difference between six or twelve days [abstract]. Gut 1996; 39 Suppl. 3: 144
93. Hermida C, Moreno JA, Carpintero P, et al. Triple therapy (omeprazol + amoxicillin + clarithromycin) for Helicobacter pylori eradication in patients with chronic gastritis. Twelve days better than six [abstract]. Gut 1996; 39 Suppl. 2: 33
94. Ho AS, Lee SC, Hsu CT, et al. What's the clinically favored triple therapy? Gut 1996; 39 Suppl. 2: A32
95. Jaspersen D, Körner T, Schorr W. Omeprazole-amoxycillin therapy for eradication of Helicobacter pylori in duodenal ulcer bleeding: preliminary results of a pilot sludy. J Gastroenterol 1995; 30 (3): 319-21
96. Jaup BH, Stenquist B, Norrby A. One-week bid therapy for H. pylori: a randomized comparison of three strategies on clinical outcome and side-effects [abstract]. Gut 1997 Oct; 41 Suppl. 3: A209
97. Jaup BH, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995 Jun; 90: 943-5
98. Jonas C, DeReuck M, Otero J, et al. Low-dose, one-week triple therapies for HP: a randomized study [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 145
99. Jonas C, Van Gossum M, De Koster L, et al. Omeprazole based therapies for eradication of Helicobacter pylori [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 125
100. Kadayifci A, Simsek H, Tatar G, et al. Low eradication rates of Helicobacter pylori with omeprazole plus amoxicilline therapy [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 127
101. Karatapanis S, Georgopoulos S, Katranis S, et al. The influence of omeprazole pre-treatment on the eradication rate of H. pyl/ori (Hp) infection [abstract]. Gut 1996 Nov; 39: 778
102. Kayser S, Flury R, Zbinden R. Comparative effects of lansoprazole/amoxixillin and omeprazole/amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients [in German]. Schweiz Mod Wochenschr 1997 Apr 26; 127: 722-7
103. Kolkman JJ, Tan TG, Oudkerk PM, et al. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1997 Dec; 11: 1123-9
104. Kung NNS, Sung JJY, Yuen NWF, et al. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Am J Gastroenterol 1997 Mar; 92: 438-41
105. Labenz J, Stolte M, Rühl GH, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995 Jan; 7: 9-11
106. Labenz J, Rühl GH, Bertrams J, et al. Clinical course of duodenal ulcer disease one year after omeprazole plus amoxycillin or triple therapy plus ranitidine for cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994 Apr; 6: 293-7
107. Labenz J, Stolte M, Domian C. High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease. Digestion 1995 Jan-Feb; 56: 14-20
108. Labenz J, Stolte M, Peitz U, et al. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996 Apr; 10: 207-10
109. Labenz J, Beker JA, Dekkers CPM, et al. Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. Aliment Pharmacol Ther 1997 Jun; 11: 515-22
110. Laine L, Johnson H, Suchower L, et al. US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 177-82
111. Laine L, Stein C, Neil G. Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing 'optimal' dosing. Am J Gastroenterol 1995 Sep; 90: 1407-10
112. Laine L, Frantz JE, Baker A. A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther 1997 Oct; 11: 913-7
113. Laine L, Estrada R, Trujillo M. Randomised comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996 Dec; 10: 1029-33
114. Lauria A, Bova F, Luverà A, et al. Long-term efficacy of omeprazole-amoxicilline-metronidazole for Helicobacter pylori eradication [abstract]. Ital J Gastroenterol 1995 Dec; 27 Suppl. 1: 144
115. Lerang F, Moum B, Ragnhildstveit E, et al. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study. Am J Gastroenterol 1997 Apr; 92: 653-8
116. Lerang F, Moum B, Haug JB, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997 Feb; 92: 248-53
117. Lind T, van Zanten V, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 Study. Helicobacter 1996: 1 (3): 138-44
118. Liu HY, Zhang ZH, Xu GM, et al. Omeprazole/amoxycillin for Helicobacter pylori eradication in Chinese patients with acid-related diseases [abstract]. J Gastroenterol Hepatol 1995; 10 Suppl. 3: 80
119. Magnano A, Pallio S, Bertino A, et al. Controlled study of omeprazole-clarithromycin-tinidazole vs ranitidine-clarithromycin-tinidazole in Helicobacter pylori-associated duodenal ulcer. Preliminary results [abstract]. Ital J Gastroenterol 1995 Dec; 27 Suppl. 1: 157
120. Malfertheiner P, Bayerdörffer E, Diete U, et al. The GU-Mach study: eradication of Helicobacter pylori, ulcer healing and relapse in gastric ulcer patients. Omeprazole and clarithromycin in combination with either amoxicillin or metronidazole [abstract]. Gut 1997; 41 Suppl. 1: 97
121. de Argilla CM, Boixeda D, Faro T, et al. Of one-week low-amoxycillin dose, triple therapy for eradication of Helicobacter pylori and clinical improvement in erosive duodenitis [abstract]. Gut 1997 Oct; 41 Suppl. 3: A207
122. Marzio L, Angelucci D, Grossi L, et al. Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol 1998; 93 (2); 223-6
123. Marzio L, Alameddine M, Angelucci D, et al. Two weeks regimen with amoxicillin, tinidazole and omeprazole eradicates Helicobacter pylori and cures active duodenal ulcer. GASUD1 (Abruzzo Group for the Study of Duodenal Ulcer) [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 159
124. Mégraud F, Pichavant R, Palegry D, et al. Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin is more effective in the eradication of Helicobacter pylori than omeprazole with clarithromycin [abstract]. Gut 1997; 41 Suppl. 1: 92
125. Meining A, Höchter W, Weingart J, et al. Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. Scand J Gastroenterol 1998; 33: 49-54
126. Meloni M, Cicu A, Carboni GP, et al. Short-term, low-dose triple therapy in gastritis Helicobacter pylori correlated [abstract]. Gut 1995; 37 Suppl. 2: 205
127. Michopoulos S, Bouzakis H, Balta A, et al. Randomized study comparing three different triple regimens containing clarithromycin for H. pylori eradication in patients with duodenal ulcer [abstract]. Gut 1997 Oct; 41 Suppl. 3: A209
128. Miehlke S, Mannes GA, Lehn N, et al. An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively. Aliment Pharmacol Ther 1997 Apr; 11: 323-9
129. Misiewicz JJ, Harris AW, Bardhan KD, et al. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 1997 Dec; 41: 735-9
130. Miwa H, Ohkura R, Murai T, et al. Effectiveness of 2 weeks OAC therapy for H. pylori infection in Japan [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 222
131. Moayyedi P, Sahay P, Tompkins DS. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995 Sep; 7: 835-40
132. Moayyedi P, Chalmers DM, Axon ATR. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1997 Feb; 32: 24-7
133. Moayyedi P, Tompkins DS, Axon ATR. Efficacy of ten days of clarithromycin, amoxicillin and omeprazole in eradicating Helicobacter pylori infection [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 169
134. Moayyedi P, Braunholtz D, Richards ID, et al. Effectiveness of omeprazole, clarithromycin and tinidazole against Helicobacter pylori in a community screening and eradication programme [abstract]. Gut 1997 Oct; 41 Suppl. 3: A213
135. Monés J, Sáinz S, Sola-Vera J, et al. Helicobacter pylori eradication with omeprazole, amoxicillin and clarithromycin: one week vs two weeks and reinfection rate at one year [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 224
136. Morgando A, Perotto C, Todros L, et al. Helicobacter pylori eradication for duodenal ulcer: no reinfection and rare recurrence at two years [abstract]. Gut 1995; 37 Suppl. 2: 237
137. Moshkowitz M, Konikoff FM, Peled Y, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther 1996 Dec; 10: 1015-9
138. Müllhaupt B, Flückiger T, Fröhli P, et al. One week low dose triple therapies with lansoprazole or omeprazole are equally effective for H. pylori eradication and ulcer healing [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 202
139. O'Connor HJ, Loane J, Cunnane K. One-week triple therapy for Helicobacter pylori incorporating high-dose clarithromycin - a prospective study [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 214
140. Otero W, Sierra F, Guitiérrez O, et al. Omeprazole plus amoxicillin in H. pylori eradication and duodenal ulcer healing. Reinfection and ulcer recurrence in an area of high prevalence of infection [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 185
141. Ovartlarnporn B, Piratvisuth T, Kalnauwakul S, et al. The efficacy of colloidal bismuth subcitrate + metronidazole + tetracycline (CMT) vs. omeprazole + metronidazole + clarithromycin (OMC) in HP eradication. A randomized controlled study [abstract]. J Gastroenterol Hepatol 1997 Dec; 12 Suppl. 1: 247
142. Ozmen MM, Patankar RV, Johnson CD. Efficacy of dual vs triple therapy and symptom relief in patients with H. pylori gastritis [abstract]. Gut 1995; 37 Suppl. 2: 167
143. Paré P, Romaozinho J, Bardhan KD, et al. Ranitidine bismuth citrate is more effective than omeprazole in the eradication of H. pylori when co-prescribed with clarithromycin [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 251
144. Passigato N, Biti L, Marconi I, et al. Comparison of three alternative strategies for Helicobacter pylori eradication in patients with chronic gastritis [abstract]. Gut 1997 Oct; 41 Suppl. 3: A210
145. Peitz U, Tillenhurg B, Becker T, et al. Highly effective well tolerated one-week triple therapy with omeprazole, clarithromycin and amoxicillin for Helicobacter pylori (Hp) infection [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 226
146. Peitz U, Nusch A, Tillenburg B, et al. High cure rate of H. pylori infection by one-week therapy with omeprazole (OME), metronidazole (MET) and clarithromycin (CLA) despite a negative impact by met resistance [abstract]. Gut 1996; 39 Suppl. 2: 5
147. Phull PS, Griffiths AE, Halliday D, et al. One week treatment for Helicobacter pylori infection: a randomised study of quadruple therapy versus triple therapy. J Antimicrob Chemother 1995 Dec; 36: 1085-8
148. Pieramico O, Zanetti MV, Innerhofer M, et al. Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial. Helicobacter 1997 Jun; 2: 92-7
149. Pieramico O, Zanetti MV, Innerhofer M. Outcome of omeprazole-based dual and triple therapy for Helicobacter pylori eradication: do gastroduodenal disease and age play a role? [abstract]. Gut 1997; 41 Suppl. 1: 91
150. Powell KU, Bell GD, Bowden AF, et al. Helicobacter pylori eradication therapy: a comparison between either omeprazole or ranitidine in combination with amoxycillin plus metronidazole. Br J Clin Res 1995; 6: 163-9
151. Powell KU, Bell GD. Bowden AF. An effective one-week Helicobacter pylori eradication therapy using omeprazole, clarithromycin and metronidazole. Br J Clin Res 1995; 6: 85-90
152. Rokkas T, Mavrogeorgis A, Liatsos C, et al. Optimal dose of omeprazole in combination with amoxicillin in eradicating H. pylori and preventing relapses in duodenal ulcer patients. Hepatogastroenterology 1995 Nov-Dec; 42: 842-6
153. Rossi P, Paoluzi OA, Tavanti A, et al. Bismute vs omeprazole in a triple therapy for eradication of Helicobacter pylori in duodenal ulcer patients [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 243
154. Saberi-Firoozi M, Massarrat S, Zare S, et al. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. Am J Gastroenterol 1995 Sep; 90: 1419-23
155. Saccà N, De Medici A, Rodinò S, et al. Duodenal ulcer Helicobacter pylori (Hp) positive: therapy with ranitidine (R) + clarithromicine (C) + metronidazole (M) versus omeprazole (O) + clarithromicine + metronidazole [abstract]. Gut 1996; 39 Suppl. 2: 34-5
156. Sambataro L, Meloni M, Carboni GP. High-dose omeprazole (OPZ) + roxithromycin (RXM) in Helicobacter pylori associated duodenal ulcer disease [abstract]. 7th Eur Congr Clin Microbiol Infect Dis 1995: 80
157. Savarino V, Zentilin P, Bisso G, et al. One-week triple therapy combining omeprazole or ranitidine with two antibiotics for eradication of Helicobacter pylori infection [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 280
158. Sito E, Konturek PC, Bielanski W, et al. One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacyer pylori infection in duodenal ulcer patients. J Physiol Pharmacol 1996 Mar; 47: 221-8
159. Sjöstedt S, Sagar M, Lindberg G, et al. Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol 1998; 33: 39-43
160. Spadaccini A, De Fanis C, Sciampa G, et al. Omeprazole versus ranitidine:
161. Spinzi G, Bortoli A, Colombo E, et al. Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1997 Apr; 11: 317-22
162. Spinzi GC, Bierti L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 433-8
163. Ström M, Sörberg M, Jönsson K-Å. Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori. Aliment Pharmacol Ther 1997 Apr; 11: 311-6
164. Sung JJY, Chung SCS, Ling TKW, et al. Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers. Dig Dis Sci 1996 Mar; 41: 453-7
165. Talong TVP et al. Triple therapy in the treatment of duodenal ulcer: a controlled and prospective study [abstract]. J Gastroenterol Hepatol 1995; 10 Suppl. 3: 76
166. Tan ACITL, den HG, Meijer JWR, et al. No additional value of bismuthsubcitrate to combination omeprazol/amoxicillin therapy in the eradication of Helicobacter pylori [abstract] Gastroenterology 1996 Apr: 110 Suppl.: 273
167. Tan WC, Hogan J, Purkayastha SK, et al. Helicobacter pylori eradication: comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis. Int J Clin Pract 1997 Jun; 51: 214-6
168. Tham TCK, Collins JSA, Molloy C, et al. Randomised controlled trial of ranitidine versus omeprazole in combination with antibiotics for eradication of Helicobacter pylori. Ulster Med J 1996 Nov; 65: 131-6
169. Thijs JC, Van Zwet AA, Thijs WJ. One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance. Aliment Pharmacol Ther 1997 Apr; 11: 305-9
170. Thijs JC, van Zweet AA, Moolenaar W. Triple therapy vs amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects. Am J Gastroenterol 1996 Jan; 91: 93-7
171. Tucci A, Poli L, Paparo GF, et al. Weekend therapy for the treatment of Helicobacter pylori infection. J Gastroenterol 1998; 93 (5): 737-42
172. Tursi A, Cammarota G, Papa A, et al. One-week low-dose triple therapy vs two-week medium-dose therapy for H. pylori infection. Hepatogastroenterology 1996 Jul-Aug; 43: 859-62
173. Tursi A, Cammarota G, Montalto M, et al. Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. Aliment Pharmacol Ther 1996 Jun; 10: 285-8
174. Tzivras M, Archimandntis A, Balatsos V, et al. One-week therapy with omeprazole, clarithromycin and metronidazole or omidazole, followed by 3 weeks treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer. Eur J Gastroenterol Hepatol 1997 Dec; 9: 1185-9
175. van der Hulst RWM, van der Ende A, Homan A, et al. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. Gut 1998; 42: 16A-9
176. van der Hulst RWM, Weel JFL, Verheul SB, et al. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol Ther 1996 Apr; 10: 165-71
177. Vautier G, Scott BB. A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice. Aliment Pharmacol Ther 1997 Feb; 11: 107-8
178. Vcev A, Vceva A, Stimac D, et al. Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients. Aliment Pharmacol Ther 1998; 12: 453-6
179. Veenendaal RA, Götz JM, Meijer JL, et al. Comparison of omeprazole and clarithromycin versus omeprazole, clarithromycin and metronidazole in the treatment of Helicobacter pylori [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 285
180. Veldhuyzen van Zanten S, Hunt RH, Cockeram A, et al. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance. Am J Gastroenterol 1998 Jan; 93: 5-10
181. Veldhuyzen van Zanten SJO, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori, ulcer healing and relapse in duodenal ulcer patients. Omeprazole and clarithromycin in combination with either amoxicillin or metronidazole [abstract]. Gut 1997; 41 Suppl. 1: 103
182. Wang K, Lin H-J, Chua RT, et al. Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease. Chung Hua I Hsueh Tsa Chih Taipei 1996 Mar; 57: 184-90
183. Weldon MJ, Broadbent A, Chambers S, et al. A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1996 Jun; 10: 279-83
184. Wurzer H, Rodrigo L, Stamler D, et al. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. Aliment Pharmacol Ther 1997 Oct; 11: 943-52
185. Yousfi MM, El-Zimaity HMT, Genta RM, et al. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1996 Aug; 10: 617-21
186. Zullo A, Rinaldi V, Pugliano F, et al. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacler pylori infection: a randomized prospective study. Am J Gastroenterol 1997 Nov; 92: 2029-31
187. Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 1997; 113 (6) Suppl.: S131-48
188. Lind T, Bardhan KD, Bayerdörffer E, et al. The MACH 2 study: optimal Helicobacter pylori therapy needs omeprazole and can be reliably assessed by UBT [abstract]. Gastroenterology 1997; 112 (4): A200
189. Lind T, Mégraud F, Bardhan KD, et al. The MACH 2 study: antimicrobial resistance in Helicobacter pylori therapy - the impact of omeprazole [abstract]. Gut 1997; 41 Suppl. 1: 89
190. Kwan WK, Chow WH, Cheung SF, et al. Comparison of lansoprazole versus omeprazole combining with metronidazole and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer [abstract]. J Gastroenterol Hepatol 1997 Dec; 12 Suppl. 1: 245
191. Spinzi GC, Bierti L, Bortoli A, et al. Comparison of a lansoprazole-based and an omeprazole-based one-week triple therapy in peptic ulcer disease [abstract]. Am J Gastroenterol 1997 Sep; 92: 1626
192. Czkwianianc E, Bak-Romaniszyn L, Lipczyk J, et al. Treatment of Helicobacter pylori infection in children: an evaluation of two different therapeutic regimens [abstract]. Gut 1997 Oct; 41 Suppl. 3: A210-1
193. Dohil R, Israel DM, Hassall E. Effective 2-wk therapy for Helicobacter pylori disease in children. Am J Gastroenterol 1997 Feb; 92: 244-7
194. Martinez MJ, Urruzuno P, Cilleruelo ML, et al. Failure of omeprazole plus amoxicillin therapy in H. pylori-infected Spanish children [abstract]. Gut 1996; 39 Suppl. 2: 48
195. Oderda G, Lerro P, Caristo P, et al. Triple therapy with omeprazole and two antibiotics in children with Helicobacter pylori gastritis [abstract]. Gut 1996; 39 Suppl. 3: 71
196. Tirén U, Sandstedt B, Bernander S, et al. Omeprazole and amoxicillin in combination is ineffective in eradicating Helicobacter pylori infection in children with antral gastritis [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 844
197. Perras C, Otten N. Pharmaceutical management of peptic ulcer disease. Technology Overview: Pharmaceuticals: No. 303, 1996 Jun, 3.2, 1-9
198. Vakil N, Fennerty MB. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer. Am J Gastroenterol 1996 Feb; 91: 239-45
199. Jönsson B. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease. Scand J Gastroenterol 1996; 31 Suppl. 215: 90-5
200. Fennerty MB. Treatment goals and treatment options of Helicobacter pylori. Gastroenterology 1997; 113 Suppl.: S120-5
201. Campbell LM. The role of a Helicobacter pylori eradication regimen (omeprazole plus amoxycillin) in the long-term management of ulcer-like dyspepsia in general practice. Br J Med Econ 1994; 7: 147-53
202. Sonnenberg A, Schwartz S, Cutler AF, et al. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomised, double-blind multicenter trial. Arch Intern Med 1998 Apr 27; 158: 852-60
203. Johnsson F, Weywadt L, Solhaug J-H, et al. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15-20
204. Schindlbeck NE, Klauser AG, Voderholzer WA. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995 Sep 11; 155: 1808-12
205. Green JRB, Tildesley G, Theodossi A, et al. Omeprazole 20 mg to 40 mg once daily is more effective than ranitidine 300 mg to 600 mg daily in providing complete symptom relief and endoscopic healing in patients with reflux oesophagitis. Br J Clin Res 1995; 6: 63-76
206. Richter JE, Sabesin SM, Kogut DG, et al. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Am J Gastroenterol 1996 Sep; 91: 1766-72
207. Kimmig JM. Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies. Aliment Pharmacol Ther 1995 Jun; 9: 281-6
208. Castell DO, Richter JE, Robinson M, et al. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. Am J Gastroenterol 1996 Sep; 91: 1749-57
209. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial. Scand J Gastroenterol 1993 Mar; 28: 224-8
210. Mee AS, Rowley JL, Lansoprazole Clinical Research Group. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole. Aliment Pharmacol Ther 1996 Oct; 10: 757-63
211. Mulder CJ, Dekker W, Gerretsen M. Lansoprazole 30mg versus omeprazole 40mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial). Eur J Gastroenterol Hepatol 1996 Nov; 8: 1101-6
212. Corinaldesi R, Valentini M, Belaiche J, et al. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study. Aliment Pharmacol Ther 1995 Dec; 9: 667-71
213. Mössner J, Hölscher AH, Herz R, et al. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Aliment Pharmacol Ther 1995 Jun; 9: 321-6
214. Iskedjian M, Einarson TR. Meta-analyses of cisapride, omeprazole and ranitidine in the treatment of GORD: implications for treating patient subgroups. Clin Drug Invest 1998 Jul; 16 (1): 9-18
215. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in Grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997 Jun; 112: 1798-810
216. Bate CM, Green JRB, Axon ATR, et al. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. Aliment Pharmacol Ther 1997 Aug; 11: 755-63
217. Carlsson R, Galmiche J-P, Dent J, et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997 Jim; 11: 473-82
218. Bate CM, Booth SN, Crowe JP. Omeprazole 10mg or 20mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995 Apr; 36: 492-8
219. Staerk-Laursen L, Havelund T, Bondesen S, et al. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol 1995 Sep; 30: 839-46
220. Dent J, Yeomans ND, MacKinnon M, et al. Omeprazole vs ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994 May; 35: 590-8
221. Hallerbäck B, Unge P, Carling L, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994 Nov; 107: 1305-11
222. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995 Oct 26; 333: 1106-10
223. Baldi F, Bardhan KD, Borman BC. Lansoprazole maintains healing in patients with reflux esophagilis [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 55
224. Carling L, Axelsson C, Forsell H, et al. Lansoprazole versus omeprazole in long term maintenance treatment of reflux oesophagitis. A Scandinavian multicentre trial [abstract]. Gut 1996; 39 Suppl. 3: 182
225. Sontag SJ, Robinson M, Roufail W, et al. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study. Aliment Pharmacol Ther 1997 Apr; 11: 373-80
226. Jasperson D, Diehl K-L, Schoeppner H, et al. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. Aliment Pharmacol Ther 1998; 12: 49-527
227. Silvis SE, Farahmand M, Johnson JA, ee al. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis. Gastrointest Endosc 1996 Mar; 43: 216-21
228. Smith PM, Kerr GD, Cockel R, et al. A comparison of omeprazole and rantitidine in the prevention of recurrence of benign esophageal stricture. Gastroenterology 1994 Nov; 107: 1312-8
229. Klinkenberg-Knol EC, International Long-Term Omeprazole Study Group. Eleven years' experience of continuous maintenance treatment with omeprazole in GERD-patients [abstract no. G0735]. Gastroenterology 1998; 114: A180
230. Bate CM, Griffin SM, Keeling PWN, et al. Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 1996 Aug; 10: 547-55
231. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998; 10: 119-24
232. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997 Oct; 32: 974-9
233. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997 Oct; 32: 965-73
234. Galmiche J-P, Barthelemy P, Hamelin B. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997 Aug; 11: 765-73
235. Lind T, Havelund T, Pedersen SA, et al. On demand treatment with omeprazole (OME) maintains quality of life (QOL) during long-term follow-up of patients with endoscopy negative reflux disease (ENRD) [abstract]. Gastroenterology 1996 Apr; 110 Suppl.: 178
236. Venables TL, Newland RD, Patel AC, et al. Maintenance treatment for gastro-oesophageal reflux disease: a placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997 Jul; 32: 627-32
237. Bate CM, Green JRB, Axon ATR, et al. Omeprazole is more etfective than cimetidine in the prevention of recurrence of GERD-associated heratburn and the occurrence of underlying oesophagitis. Aliment Pharmacol Ther 1998; 12: 41-7
238. Kane RE, Sarr M, Foy TM. Omeprazole versus lansoprazole in the treatment of children with peptic esophagitis refractory to H2 antagonists [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 166
239. Strauss R, Calenda K, Dayal V, et al. Clinical and histological response to omeprazole in children with resistant esophagitis [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 227
240. De Giacomo C, Bawa P, Franceschi M, et al. Omeprazole for severe reflux esophagitis in children. J Pediatr Gastroenterol Nutr 1997 May; 24: 528-32
241. Martin PB, Imong SM, Krischer J, et al. The use of omeprazole for resistant oesophagitis in children. Eur J Pediatr Surg 1996 Aug; 6: 195-7
242. Karjoo M, Kane R. Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. Arch Pediatr Adolesc Med 1995 Mar; 149: 267-71
243. Hassall E, Israel DM, Shepherd R, et al. Omeprazole for chronic erosive esophagitis in children: a multicenter study of dose requirements for healing [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 143
244. Hillman AL. Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease. Scand J Gastroenterol 1994; 29 Suppl. 201: 98-101
245. Bate CM, Richardson PDI. Cost-effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice. Br J Med Econ 1994: 7: 81-97
246. Green JRB, Bate CM, Copeman MB, et al. A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagilis. Br J Med Econ 1995; 8: 157-69
247. Phillips C, Moore A. Trial and error - an expensive luxury: economic analysis of effectiveness of proton pump inhibitors and histamine antagonists in treating reflux disease. Br J Med Econ 1997; 11: 55-63
248. Bloom BS, Hillman AL, LaMont B, et al. Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis: a cost-effectiveness analysis. Pharmacoeconomics 1995 Oct; 8: 343-9
249. Hotz J, Kark W, Plein K, et al. Management of acute gastroduodenal peptic ulcer: superiority of omeprazole to ranitidine in the early phase of ulcer healing [in German]. Leber Magen Darm 1995 Jul; 25: 165-70
250. Perras C, Otten N. Pharmaceutical management of gastroesophageal reflux disease. Technology Overview: Pharmaceuticals. 1996 Jun, 3.2, 1-9
251. Heudebert GR, Marks R, Wilcox CM. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology 1997 Apr; 112: 1078-86
252. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antimflammatory drugs. N Engl J Med 1998 Mar 12; 338 (11): 727-34
253. Yeomans ND, Tulassay Z, Juhász L, et al. A comparison of omeprazole with ranitidine for ulcers associated with non-steroidal antimflammatory drugs. N Engl J Med 1998 Mar 12; 338 (11): 719-26
254. Ekström P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy: a Nordic multicentre study. Scand J Gastroenterol 1996 Aug; 31: 753-8
255. Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998; 12: 135-40
256. Jonsson B, Wahlqvist P. Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective. Am J Med 1998; 104 Suppl. 3: 81S-8S
257. Anonymous. Losec* Capsules 10mg 20mg and 40mg. In: ABPI Compendium of Data Sheets and Summaries of Product Characteristics. London: ABPI, 1997: 77-8 (Y)
258. Shindo K, Machida M, Fukumuru M, et al. Omeprazole induces altered bile acid metabolism. Gut 1998; 42: 266-71
259. Murphy GM. Depressing acid, deconjugating bile. Gut 1998; 42: 154
260. Saltzman JR, Kowdley KV, Pedrosa MC, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric patients. Gastroenterology 1994; 106: 615-23
261. Borum ML, Cannava M. Diffuse alopecia associated with omeprazole [letter]. Am J Gastroenterol 1997 Sep; 92: 1576
262. Epelde-Gonzalo FD, Boada-Montagul L, Tomás-Vecina S. Exfoliative dermatitis related to omeprazole [letter]. Ann Pharmacother 1995 Jan; 29: 82-3
263. Stenier C, Fiasse R, Bourlond J, et al. Bullous skin reaction induced by omeprazole [letter]. BrJ Dermatol 1995 Aug; 133: 343-4
264. Ricci RM, Deering KC. Erythema nodosum caused by omeprazole. Cutis 1996 Jun; 57: 434
265. O'Donnell D. Acute renal failure due to omeprazole. Med J Aust 1996 Aug 19; 165: 234-5
266. Ottervanger JP, Stricker BHC, Kappelle JW, et al. Omeprazole-associated agranuloeytosis [letter]. Eur J Haematol 1995 Apr; 54: 279-80
267. Ottervanger JP, Phaff RAS, Vermeiden EGJ. Anaphylaxis to omeprazole. J Allergy Clin Immunol 1996 Jun; 97: 1413-4
268. Fireman Z, Kopelman Y, Sternberg A, et al. Central nervous system side effects after proton pump inhibitor treatment: what are the treatment goals for Helicobacter pylori infection? [letter]. J Clin Gastroenterol 1997 Dec; 25: 718
269. Meeuwisse EJM, Groen FC, Dees A. Lethargy with omeprazole. BMJ 1997 Feb 15; 314: 481
270. Varona L, Ruiz J, Zarranz J-J. Gait ataxia during omeprazole therapy. Ann Pharmacother 1996 Feb; 30: 192
271. Kraus A, Flores-Suárez LF. Acute gout associated with omeprazole [letter]. Lancet 1995 Feb 18; 345: 461-2
272. Brunner G, Athmann C, Hollenz M. Experience with omeprazole in pregnancy [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 79
273. Walan A, Joelson S, Blom H, et al. Adverse event profile during long term treatment with omeprazole [abstract no. G0193]. Gastroenterology 1998; 114 Suppl. A: A48
274. Pospai D, Cadiot G, Vissuzaine C, et al. Fundic mucosa of GER patients continuously treated with ranitidine: comparison with omeprazole-treated patients and controls [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 194
275. El-Zimaity HMT, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 1997 Oct; 92: 1858-60
276. Israel DM, Hassall E, Dimmick JE. Gastric polyps in children receiving omeprazole [abstract]. Gastroenterology 1995 Apr; 108 Suppl.: 121
277. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Gastric polyps during long-term omeprazole treatment for gastroesophageal reflux disease [abstract]. Gastroenterology 1997 Apr; 112 Suppl.: 281
278. Mogadam M, Houk RR. Long-term use of omeprazole is associated with development of benign epithelial gastric polyps [abstract]. Am J Gastroenterol 1996 Sep; 91: 1921
279. Stolte M, Bethke B, Seifert E, et al. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol 1995 Mar; 33: 146-9
280. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996 Apr 18; 334: 1018-22
281. Lundell L, Havu N, Andersson A, et al. Gastritis development and acid suppression therapy revisited: results of a randomised clinical study with long term follow-up. Gastroenterology 1997 Apr; 112 (4) Suppl.: A28
282. Proton pump inhibitor relabeling for cancer risk not warranted. FDC Pink 1996 Nov 11; 58: 1-2
283. El-Nujumi A, Williams C, Ardill JE, et al. Eradicating Helicobacter pylori reduces hypergastrinaemia during long term omeprazole treatment. Gut 1998; 42: 159-65
284. European Helicobacter Pylori Study Group (EHPSG). Current European concepts in the management of Helicobacter pylori infection: the Maastricht consensus report. Gut 1997; 41: 8-13
285. Olafsson S, Malm D, Olafsson T. Efficacy and side effects of bismuth-based triple therapy and dual therapy with omeprazole and amoxicillin in eradication of Helicobacter pylori in routine hospital practice [abstract]. Gut 1995; 37 Suppl. 2: 54
286. Astra Hässle AB. Omeprazole international data sheet. 1998-04-06. Mölndal, Sweden
287. de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. Eur J Gastroenterol Hepatol 1996 Jul; 8: 709-16
288. Hunt R, Thomson ABR, Consensus Conference Participants. Canadian Helicobacter pylori consensus conference. Can J Gastroenterol 1998 Jan/Feb; 12(1): 31-41
289. Walters JK, Zimmermann AE, Souney PF, et al. The use of omeprazole in the paediatric population. Ann Pharmacother 1998 Apr; 32: 478-81
290. Jaruratanasirikul S, Sriwiriyajan S. Effect of omeprazole on the pharmacokinetics of itraconazole. Eur J Clin Pharmacol 1998; 54: 159-61
291. Soll AH. Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease: practice guidelines. JAMA 1996 Feb 28; 275: 622-9
292. Lee J, O'Morain C. Who should he treated for Helicobacter pylori infection? A review of consensus conferences and guidelines. Gastroenterology 1997 Dec; 113 Suppl.: 99-106
293. Kang JY, Fock KM, Ng HS, et al. Working party report of the Gastroenterological Society of Singapore Part I - Helicobacter pylori and peptic ulcer disease in Singapore. Singapore Med J 1996 Jun; 37: 304-6
294. Penston JG, McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997 Mar; 43: 223-43
295. Hoffman JS. Pharmacological therapy of Helicobacter pylori infection. Semin Gastrointest Dis 1997 Jul; 8: 156-63
296. Smallwood R. The management of acid peptic disease. Aust Prescr 1995; 18 (4): 97-9
297. Van der Hulst RWM, Tytgat GNJ. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol 1996; 31 Suppl. 220: 10-8
298. Best regimens for H pylori eradication. Scrip 1997 Jun 17 (2241): 21
299. Vakil N. Treatment of Helicobacter pylori infection. Am J Ther 1998; 5: 197-201
300. The medical management of gastro-oesophageal reflux. Drug Ther Bull 1996 Jan; 34: 1-4
301. Vandenplas Y, Ashkenazi A, Belli D, et al. Reflux esophagitis in infants and children: a report from the Working Group on Gastro-Oesophageal Reflux Disease of the European Society of Paediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1994 May; 18: 413-22
302. Hassall E. Wrap session: is the Nissen slipping? Can medical treatment replace surgery for severe gastroesophageal reflux disease in children? Am J Gastroenterol 1995 Aug; 90: 1212-20
303. Lee M. Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropaihy. South Med J 1995 May; 88: 307-13
304. Chan FKL, Sung JJY, Chung SCS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9